ClinicalTrials.govpublic full text
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
immune checkpoint therapy, radiotherapy, metastatic colorectal cancer (crc), interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828325
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.